Rosenberg H C, Chiu T H
Eur J Pharmacol. 1981 Apr 9;70(4):453-60. doi: 10.1016/0014-2999(81)90356-3.
Studies were performed to evaluate the time course and possible significance of changes in specific benzodiazepine binding that occur chronic treatment. Rats were offered flurazepam in a saccharin solution as their only fluid supply. Each rats consumed 100-150 mg/kg daily. Such treatment produced no change in the binding constant (KD) of specific [3H]flunitrazepam binding. Maximal binding capacity (Bmax) was reduced by about 20% after 4 or 8 weeks of treatment, but not by 2 weeks or less. Bmax returned to control within 24 h after the end of chronic treatment. Rats were tested for susceptibility to flurazepam by injecting 20-200 mg/kg i.p., and assessing locomotor impairment. Dose-response analysis showed tolerance only after treatments and at times when Bmax was reduced. The results suggest that the reduced Bmax is an adaptive change in response to chronic benzodiazepine treatment, and that the mechanism for tolerance is a reduction of receptors.
开展了多项研究以评估长期治疗过程中特定苯二氮䓬结合变化的时间进程及可能的意义。给大鼠提供含氟西泮的糖精溶液作为其唯一的液体供应。每只大鼠每天摄入100 - 150毫克/千克。这种治疗对特异性[³H]氟硝西泮结合的结合常数(KD)没有影响。治疗4周或8周后,最大结合容量(Bmax)降低了约20%,但2周或更短时间则未降低。长期治疗结束后24小时内,Bmax恢复至对照水平。通过腹腔注射20 - 200毫克/千克氟西泮并评估运动功能损害,来检测大鼠对氟西泮的敏感性。剂量反应分析表明,仅在治疗后以及Bmax降低时出现耐受。结果提示,Bmax降低是对长期苯二氮䓬治疗的一种适应性变化,且耐受机制是受体减少。